The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy

被引:10
作者
Crocetti, Emanuele
Battisti, Laura
Betta, Alberto
Palma, Paolo Dalla
Paci, Eugenio
Piffer, Silvano
Pojer, Ada
Polla, Enzo
Zappa, Marco
机构
[1] CSPO, Clin & Descript Epidemiol Unit, Sci Inst Tuscan Reg, I-50135 Florence, Italy
[2] Santa Chiara Hosp, Dept Publ Hlth, Local Hlth Unit, Trento, Italy
[3] Santa Chiara Hosp, Pathol Unit, Trento, Italy
关键词
adenocarcinoma; cervical cancer; Pap test; screening;
D O I
10.1097/CEJ.0b013e3280145c14
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the effectiveness of a cytological screening to prevent invasive cervical cancer in the province of Trento, a northern Italian area where a population-based cancer registry is active. The history of Pap test was evaluated through a case-control study in 61 population-based invasive cervical cancer patients, incident during 1995-2000, and in 244 age-matched (between 25 and 75 years old) controls. Women who had at least one Pap test had a reduced risk of invasive carcinoma of 80% (odds ratio= 0.20; 95% confidence intervals 0.10-0.40). The protection of a previous Pap test for both squamous cell carcinoma (odds ratio=0.23; 95% confidence intervals 0.09-0.58) and adenocarcinoma (odds ratio=0.24; 95% confidence intervals 0.07-0.78) was similar. The overall protective effect of the Pap test was not seen among younger women (<40 years). The protective effect of the Pap test seems to be stronger for shorter intervals. Our study confirms that Pap-test screening, particularly in middle-aged and older women, is an effective public health intervention with encouraging results also for the prevention of cervical adenocarcinoma.
引用
收藏
页码:564 / 567
页数:4
相关论文
共 15 条
[1]  
[Anonymous], 2006, Journal of the National Cancer Institute
[2]  
Bai HW, 2000, DIAGN CYTOPATHOL, V23, P19, DOI 10.1002/1097-0339(200007)23:1<19::AID-DC4>3.0.CO
[3]  
2-K
[4]  
BELLU F, 2002, IARC SCI PUBL, V155, P372
[5]   Performance indicators of organized cervical screening in Romagna (Italy) [J].
Bucchi, L ;
Falcini, F ;
Schincaglia, P ;
Desiderio, F ;
Bondi, A ;
Farneti, M ;
Giunchi, DC ;
Serafini, M ;
Canuti, D ;
Caprara, L ;
Sabbadini, F ;
Monari, F ;
Sassoli, P .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (03) :223-228
[6]   Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening [J].
Mitchell, H ;
Hocking, J ;
Saville, M .
CANCER CYTOPATHOLOGY, 2003, 99 (06) :336-341
[7]   CERVICAL CYTOLOGY REPORTED AS NEGATIVE AND RISK OF ADENOCARCINOMA OF THE CERVIX - NO STRONG EVIDENCE OF BENEFIT [J].
MITCHELL, H ;
MEDLEY, G ;
GORDON, I ;
GILES, G .
BRITISH JOURNAL OF CANCER, 1995, 71 (04) :894-897
[8]   A SURVEY OF THE ACTUALITIES AND POTENTIALITIES OF EXFOLIATIVE CYTOLOGY IN CANCER DIAGNOSIS [J].
PAPANICOLAOU, GN .
ANNALS OF INTERNAL MEDICINE, 1949, 31 (04) :661-674
[9]   The cervical cancer epidemic that screening has prevented in the UK [J].
Peto, J ;
Gilham, C ;
Fletcher, O ;
Matthews, FE .
LANCET, 2004, 364 (9430) :249-256
[10]   Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England [J].
Sasieni, P ;
Adams, J .
LANCET, 2001, 357 (9267) :1490-1493